INHIBITOREN VON LYSIN-GINGIPAIN

Patent europeic · EP3204352 · Stritgà

Inscripziun en il register

Numer da publicaziun: EP3204352
Numer da la dumonda: EP15849799
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: Stritgà
Scrittira da patent: Concedì
Annunzià: 05-10-2015
Publitgà: 16-08-2017
Concedì: 01-07-2020
Stritgà: 25-05-2024
Motiv: Taxa annuala betg pajada
Classas IPC: C07C 233/62 (2006.01)
C07D 277/28 (2006.01)
C07D 277/64 (2006.01)
C07D 277/24 (2006.01)
C07D 417/12 (2006.01)
C07D 409/12 (2006.01)
C07D 213/50 (2006.01)
C07D 213/53 (2006.01)
A61K 31/4402 (2006.01)
A61K 31/428 (2006.01)
A61K 31/426 (2006.01)
A61P 31/04 (2006.01)
Prioritad: US 201462060483 P 06.10.2014
Dumonda PCT: PCT/US2015/054050 05.10.2015
Publicaziun PCT: WO2016/057413 14.04.2016
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

25-05-2024
Stritgà, taxa betg pajada
Published in Swissreg on 25.05.2024
14-04-2023
Represchentant stritgà
Representative
VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern (allontanà)
Published in Swissreg on 14.04.2023
14-04-2023
Represchentant inscrit
Representative
Isler & Pedrazzini AG, Postfach, 8027 Zürich
Published in Swissreg on 14.04.2023
14-04-2023
Adressa midada
Owner
Cortexyme, Inc., 329 Oyster Point, Suite 300, South San Francisco, CA 94080, USA → Quince Therapeutics, Inc., 601 Gateway Blvd., Suite 1250, South San Francisco, CA 94080, USA
Published in Swissreg on 14.04.2023
01-11-2022
Midada
Published in Swissreg on 01.11.2022
01-10-2020
Represchentant inscrit
Representative
VENI GmbH, Villa de Meuron, Buristrasse 21, 3006 Bern
Published in Swissreg on 01.10.2020
01-07-2020
Concedì
Published in Swissreg on 01.07.2020

601 Gateway Blvd., Suite 1250, South San Francisco, CA 94080, US

Postfach, 8027 Zürich